Triamterene and Hydrochlorothiazide

Product NDC
50090-1834
11-digit product format
500901834
Labeler code
50090
Product ID
50090-1834_b7aace6d-e542-4a86-9e45-8c2e690daca4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Triamterene and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA071851
Marketing category
ANDA
Marketing start
1993-09-23
Substance
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Active strength
50; 75 mg/1; mg/1
Pharmacologic classes
Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE
WS821Z52LQTRIAMTERENE396-01-0TRIAMTERENE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50090-1834-05009018340030 TABLET in 1 BOTTLE (50090-1834-0) 30 tablet2015-05-19NoNoHistorical
50090-1834-250090183402100 TABLET in 1 BOTTLE (50090-1834-2) 100 tablet2015-05-19NoNoHistorical
50090-1834-55009018340590 TABLET in 1 BOTTLE (50090-1834-5) 90 tablet2015-07-29NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Triamterene and Hydrochlorothiazide Tablets, USP Revised: November 2020 Rx onlyA-S Medication Solutions2023-12-10HUMAN PRESCRIPTION DRUG LABEL11